[Interview Series] Interviews on the NCD Alliance Japan website – Ms. Yukiko Nishimura “Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases” (June 15, 2020)
date : 6/16/2020
The mission of NCD Alliance Japan* is to achieve the creation of a system for NCD policy that is centered on the involvement of people receiving healthcare and other parties most affected by NCDs. To achieve this, it educates and supports leaders from among those most affected by NCDs so they can actively participate in policy creation, such as by serving on national committees and councils.
Please access the links below for the interview:
■ Ms. Yukiko Nishimura NEW
President, Advocacy Service for Rare and Intractable Diseases (NPO ASrid)
“Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases”
■ Mr. Hiroki Takeda
Chief Knowledge Officer, PPeCC (Power to the People with Chronic Conditions)
Executive Director, Japan Chronic Disease Self-Management Association
“Supporting the Activities of People Living with NCDs to Build an NCD-Friendly Society”
■ Mr.Shinsuke Amano
Chair, The Japan Federation of Cancer Patient Groups
CEO, Group Nexus Japan
“Collaborating across NCDs to achieve “societies in which even people affected by cancer can live with peace of mind””
■ Mr. Takeshi Shukunobe
President and CEO, PPeCC
President and CEO, Patienthood
“Creating a better healthcare environment through a collaborative platform involving people with NCDs and other people most affected”
*NCD Alliance Japan is a collaborative platform for civil society organizations in the NCD community, steered by the Health and Global Policy Institute, aiming to further promote comprehensive, cross-cutting NCD policies.
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)



